Literature DB >> 8216537

Carbohydrate-deficient glycoprotein syndromes: peculiar group of new disorders.

B A Hagberg1, G Blennow, B Kristiansson, H Stibler.   

Abstract

A new group of metabolic disorders, the carbohydrate-deficient glycoprotein (CDG) syndromes, is reviewed with emphasis on the key condition, the CDG syndrome type I. This disease, an autosomal-recessive multisystem condition, has now been diagnosed in 45 Scandinavian patients. It is characterized by carbohydrate deficiencies of a number of glycoproteins, including uniform changes in transferrin. The transferrin alterations provide a distinct biologic marker and a practical and simple laboratory diagnostic means employing analysis of serum or blood spots from Guthrie-type filter paper. The syndrome presents differently through various life periods. A four-stage grouping system by age has been constructed and is presented. During infancy, internal organ symptoms are dominant; some may be life-threatening. In later childhood and adolescence, static mental deficiency, cerebellar ataxia, slowly progressive lower limb neuropathy, and pigmentary retinal degeneration, as well as secondary skeletal deformities, are the most prominent findings. Two very recently described clinical and biologic variants, CDG syndromes II and III, are summarized and compared to CDG type I.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8216537     DOI: 10.1016/0887-8994(93)90060-p

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  23 in total

Review 1.  New disorders in carbohydrate metabolism: congenital disorders of glycosylation and their impact on the endocrine system.

Authors:  Bradley S Miller; Hudson H Freeze
Journal:  Rev Endocr Metab Disord       Date:  2003-03       Impact factor: 6.514

2.  Neurology of inherited glycosylation disorders.

Authors:  Hudson H Freeze; Erik A Eklund; Bobby G Ng; Marc C Patterson
Journal:  Lancet Neurol       Date:  2012-05       Impact factor: 44.182

3.  The heart and pericardial effusions in CDGS-I (carbohydrate-deficient glycoprotein syndrome type I).

Authors:  B Kristiansson; H Stibler; N Conradi; B O Eriksson; W Ryd
Journal:  J Inherit Metab Dis       Date:  1998-04       Impact factor: 4.982

Review 4.  Investigation of developmental delay.

Authors:  R W Newton; J E Wraith
Journal:  Arch Dis Child       Date:  1995-05       Impact factor: 3.791

5.  Isoelectric focusing of Tamm-Horsfall glycoproteins: a simple tool for recognizing recurrent calcium oxalate renal stone formers.

Authors:  P Schnierle; F Hering; H Seiler
Journal:  Urol Res       Date:  1996

6.  Carbohydrate deficient glycoprotein syndrome--like transferrin isoelectric focusing pattern in untreated fructosaemia.

Authors:  M Adamowicz; E Pronicka
Journal:  Eur J Pediatr       Date:  1996-04       Impact factor: 3.183

7.  High residual activity of PMM2 in patients' fibroblasts: possible pitfall in the diagnosis of CDG-Ia (phosphomannomutase deficiency).

Authors:  S Grünewald; E Schollen; E Van Schaftingen; J Jaeken; G Matthijs
Journal:  Am J Hum Genet       Date:  2001-01-11       Impact factor: 11.025

8.  Three families with mild PMM2-CDG and normal cognitive development.

Authors:  Mari-Anne Vals; Eva Morava; Kai Teeäär; Riina Zordania; Sander Pajusalu; Dirk J Lefeber; Katrin Õunap
Journal:  Am J Med Genet A       Date:  2017-04-19       Impact factor: 2.802

9.  Neuroradiological findings in the carbohydrate-deficient glycoprotein syndrome.

Authors:  S Akaboshi; K Ohno; K Takeshita
Journal:  Neuroradiology       Date:  1995-08       Impact factor: 2.804

10.  Carbohydrate-deficient glycoprotein syndrome: not an N-linked oligosaccharide processing defect, but an abnormality in lipid-linked oligosaccharide biosynthesis?

Authors:  L D Powell; K Paneerselvam; R Vij; S Diaz; A Manzi; N Buist; H Freeze; A Varki
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.